(XOM) Exxon Mobil - Ratings and Ratios
Crude Oil, Natural Gas, Petrochemicals, Fuels, Lubricants
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 21.2% |
| Value at Risk 5%th | 36.3% |
| Relative Tail Risk | 4.17% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.01 |
| Alpha | -7.61 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.479 |
| Beta | 0.522 |
| Beta Downside | 0.839 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.92% |
| Mean DD | 7.89% |
| Median DD | 7.57% |
Description: XOM Exxon Mobil September 24, 2025
Exxon Mobil Corp (NYSE:XOM) is an integrated oil-and-gas company that explores for and produces crude oil and natural gas across a global footprint that includes the United States, Canada, the United Kingdom, Singapore, France and other international locations. Its operations are organized into four segments: Upstream (exploration and production), Energy Products (fuels, aromatics, catalysts and licensing), Chemical Products (olefins, polyolefins and intermediates) and Specialty Products (lubricants, basestocks, waxes, synthetics, elastomers and resins). The firm also pursues lower-emission initiatives such as carbon capture and storage, hydrogen, low-carbon fuels, Proxxima systems, carbon materials and lithium, and markets its output under the Exxon, Esso and Mobil brands.
Key recent metrics illustrate the scale and financial health of the business: in 2023 ExxonMobil generated roughly $30 billion of free cash flow and paid a dividend yielding about 3.8%, while upstream net production averaged 3.7 million barrels of oil equivalent per day. Capital spending remained elevated at roughly $15 billion, reflecting continued investment in both conventional projects and emerging low-carbon technologies. A primary sector driver is the modest but persistent growth in global oil demand (≈1.5 % yr⁻¹) combined with OPEC+ output management, which together shape price expectations and downstream margins.
For a deeper, data-driven assessment of XOM’s valuation and risk profile, you may find it useful to explore the analyst tools available on ValueRay.
XOM Stock Overview
| Market Cap in USD | 500,937m |
| Sub-Industry | Integrated Oil & Gas |
| IPO / Inception | 1978-01-13 |
| Return 12m vs S&P 500 | -9.74% |
| Analyst Rating | 3.93 of 5 |
XOM Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 3.41% |
| Yield on Cost 5y | 12.44% |
| Yield CAGR 5y | 2.49% |
| Payout Consistency | 68.2% |
| Payout Ratio | 57.6% |
XOM Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 4.67% |
| CAGR/Max DD Calmar Ratio | 0.25 |
| CAGR/Mean DD Pain Ratio | 0.59 |
| Current Volume | 15903.7k |
| Average Volume | 15001.1k |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (29.95b TTM) > 0 and > 6% of Revenue (6% = 19.50b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -1.86pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.28% (prev 7.17%; Δ -3.89pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 51.52b > Net Income 29.95b (YES >=105%, WARN >=100%) |
| Net Debt (53.27b) to EBITDA (68.77b) ratio: 0.77 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (4.33b) change vs 12m ago -2.94% (target <= -2.0% for YES) |
| Gross Margin 22.27% (prev 22.71%; Δ -0.44pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 70.92% (prev 73.58%; Δ -2.66pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 44.80 (EBITDA TTM 68.77b / Interest Expense TTM 980.0m) >= 6 (WARN >= 3) |
Altman Z'' 7.15
| (A) 0.02 = (Total Current Assets 88.50b - Total Current Liabilities 77.85b) / Total Assets 454.34b |
| (B) 1.06 = Retained Earnings (Balance) 480.37b / Total Assets 454.34b |
| warn (B) unusual magnitude: 1.06 — check mapping/units |
| (C) 0.10 = EBIT TTM 43.90b / Avg Total Assets 458.13b |
| (D) 2.76 = Book Value of Equity 514.39b / Total Liabilities 186.12b |
| Total Rating: 7.15 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.25
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 4.29% = 2.14 |
| 3. FCF Margin 7.32% = 1.83 |
| 4. Debt/Equity 0.26 = 2.47 |
| 5. Debt/Ebitda 0.77 = 2.05 |
| 6. ROIC - WACC (= 3.33)% = 4.17 |
| 7. RoE 11.42% = 0.95 |
| 8. Rev. Trend -42.89% = -3.22 |
| 9. EPS Trend -82.84% = -4.14 |
What is the price of XOM shares?
Over the past week, the price has changed by +0.22%, over one month by +5.04%, over three months by +10.20% and over the past year by +2.55%.
Is XOM a buy, sell or hold?
- Strong Buy: 10
- Buy: 7
- Hold: 10
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the XOM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 127.4 | 8.5% |
| Analysts Target Price | 127.4 | 8.5% |
| ValueRay Target Price | 125.7 | 7.1% |
XOM Fundamental Data Overview November 15, 2025
P/E Trailing = 17.266
P/E Forward = 16.1551
P/S = 1.5355
P/B = 1.9117
P/EG = 2.786
Beta = 0.378
Revenue TTM = 324.92b USD
EBIT TTM = 43.90b USD
EBITDA TTM = 68.77b USD
Long Term Debt = 32.80b USD (from longTermDebt, last fiscal year)
Short Term Debt = 9.21b USD (from shortTermDebt, last quarter)
Debt = 67.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 53.27b USD (from netDebt column, last quarter)
Enterprise Value = 554.21b USD (500.94b + Debt 67.14b - CCE 13.87b)
Interest Coverage Ratio = 44.80 (Ebit TTM 43.90b / Interest Expense TTM 980.0m)
FCF Yield = 4.29% (FCF TTM 23.77b / Enterprise Value 554.21b)
FCF Margin = 7.32% (FCF TTM 23.77b / Revenue TTM 324.92b)
Net Margin = 9.22% (Net Income TTM 29.95b / Revenue TTM 324.92b)
Gross Margin = 22.27% ((Revenue TTM 324.92b - Cost of Revenue TTM 252.56b) / Revenue TTM)
Gross Margin QoQ = 22.42% (prev 22.58%)
Tobins Q-Ratio = 1.22 (Enterprise Value 554.21b / Total Assets 454.34b)
Interest Expense / Debt = 0.31% (Interest Expense 207.0m / Debt 67.14b)
Taxrate = 28.94% (3.16b / 10.93b)
NOPAT = 31.20b (EBIT 43.90b * (1 - 28.94%))
Current Ratio = 1.14 (Total Current Assets 88.50b / Total Current Liabilities 77.85b)
Debt / Equity = 0.26 (Debt 67.14b / totalStockholderEquity, last quarter 260.56b)
Debt / EBITDA = 0.77 (Net Debt 53.27b / EBITDA 68.77b)
Debt / FCF = 2.24 (Net Debt 53.27b / FCF TTM 23.77b)
Total Stockholder Equity = 262.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.59% (Net Income 29.95b / Total Assets 454.34b)
RoE = 11.42% (Net Income TTM 29.95b / Total Stockholder Equity 262.39b)
RoCE = 14.87% (EBIT 43.90b / Capital Employed (Equity 262.39b + L.T.Debt 32.80b))
RoIC = 10.36% (NOPAT 31.20b / Invested Capital 301.11b)
WACC = 7.03% (E(500.94b)/V(568.08b) * Re(7.94%) + D(67.14b)/V(568.08b) * Rd(0.31%) * (1-Tc(0.29)))
Discount Rate = 7.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 3.93%
[DCF Debug] Terminal Value 76.58% ; FCFE base≈27.38b ; Y1≈24.54b ; Y5≈20.93b
Fair Price DCF = 89.75 (DCF Value 378.47b / Shares Outstanding 4.22b; 5y FCF grow -12.80% → 3.0% )
EPS Correlation: -82.84 | EPS CAGR: -19.38% | SUE: 0.54 | # QB: 0
Revenue Correlation: -42.89 | Revenue CAGR: -3.97% | SUE: -0.04 | # QB: 0
Additional Sources for XOM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle